ATRC insider transaction filings
AtriCure, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-14. Screen ATRC transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 15 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 9 filings by 8 insiders — 70,349 shares, $3,046,757 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 25,000 shares @ $37.84 ($946,000) by WEHRWEIN SVEN, filed 2026-07-30.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| WEHRWEIN SVEN — Director | 1 | — | 1 leg · 25,000 sh · $946,000 | 2 |
| Privitera Salvatore — Chief Technical Officer | 3 | — | 2 legs · 11,420 sh · $608,692 | 1 |
| Dahlquist Karl S. — Chief Legal Officer | 2 | — | 1 leg · 9,370 sh · $458,099 | 1 |
| GROVES REGINA E — Director | 1 | — | 1 leg · 5,313 sh · $288,071 | — |
| Noznesky Justin J — Chief Mktg & Strategy Officer | 1 | — | 1 leg · 6,182 sh · $239,862 | — |
| Doraiswamy Vinayak — Chief Scientific Officer | 2 | — | 1 leg · 6,000 sh · $233,280 | 1 |
| Prange Karen — Director | 1 | — | 1 leg · 3,564 sh · $138,283 | — |
| Yuen Maggie — Director | 1 | — | 1 leg · 3,500 sh · $134,470 | — |
| CARREL MICHAEL H — President, CEO, & Director, Director | 2 | — | — | 3 |
| Seith Douglas J — Chief Operating Officer | 1 | — | — | 1 |
Recent Form 4 filings — AtriCure, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | GROVES REGINA E — Director | Sale (S): 5,313 @ $54.22 | EDGAR |
| 2026-09-10 | 4 | Privitera Salvatore — Chief Technical Officer | Sale (S): 3,657 @ $55 | EDGAR |
| 2026-09-04 | 4 | Privitera Salvatore — Chief Technical Officer | Sale (S): 7,763 @ $52.50 | EDGAR |
| 2026-08-26 | 4 | Dahlquist Karl S. — Chief Legal Officer | Sale (S): 9,370 @ $48.89 | EDGAR |
| 2026-08-07 | 4 | Yuen Maggie — Director | Sale (S): 3,500 @ $38.42 | EDGAR |
| 2026-08-07 | 4 | Prange Karen — Director | Sale (S): 3,564 @ $38.80 | EDGAR |
| 2026-08-03 | 4 | CARREL MICHAEL H — President, CEO, & Director, Director | Gift (G): 700 @ $0 · Gift (G): 4,000 @ $0 | EDGAR |
| 2026-07-30 | 4 | Noznesky Justin J — Chief Mktg & Strategy Officer | Sale (S): 6,182 @ $38.80 | EDGAR |
| 2026-07-30 | 4 | WEHRWEIN SVEN — Director | Option exercise (M): 25,000 @ $19.95 · Sale (S): 25,000 @ $37.84 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-07-30 | 4 | Doraiswamy Vinayak — Chief Scientific Officer | Sale (S): 6,000 @ $38.88 | EDGAR |
| 2026-07-02 | 4 | Doraiswamy Vinayak — Chief Scientific Officer | Grant/award (A): 636 @ $23.78 | EDGAR |
| 2026-07-02 | 4 | Dahlquist Karl S. — Chief Legal Officer | Grant/award (A): 636 @ $23.78 | EDGAR |
| 2026-07-02 | 4 | Seith Douglas J — Chief Operating Officer | Grant/award (A): 527 @ $23.78 | EDGAR |
| 2026-07-02 | 4 | Privitera Salvatore — Chief Technical Officer | Grant/award (A): 636 @ $23.78 | EDGAR |
| 2026-07-02 | 4 | CARREL MICHAEL H — President, CEO, & Director, Director | Grant/award (A): 636 @ $23.78 | EDGAR |
| 2026-05-22 | 4 | Prange Karen — Director | Sale (S): 3,000 @ $28.65 | EDGAR |
| 2026-05-20 | 4 | Nachman Shlomo — Director | Grant/award (A): 6,144 @ $0 | EDGAR |
| 2026-05-20 | 4 | Telman Deborah H — Director | Grant/award (A): 6,144 @ $0 | EDGAR |
| 2026-05-20 | 4 | Yuen Maggie — Director | Grant/award (A): 6,144 @ $0 | EDGAR |
| 2026-05-20 | 4 | GROVES REGINA E — Director | Grant/award (A): 6,144 @ $0 | EDGAR |
| 2026-05-20 | 4 | WHITE ROBERT S. — Director | Grant/award (A): 6,144 @ $0 | EDGAR |
| 2026-05-20 | 4 | Prange Karen — Director | Grant/award (A): 6,144 @ $0 | EDGAR |
| 2026-05-20 | 4 | JOHNSON B KRISTINE — Director | Grant/award (A): 6,144 @ $0 | EDGAR |
| 2026-05-20 | 4 | WEHRWEIN SVEN — Director | Grant/award (A): 6,144 @ $0 | EDGAR |
| 2026-05-18 | 4 | Doraiswamy Vinayak — Chief Scientific Officer | Sale (S): 5,000 @ $28.13 | EDGAR |
| 2026-03-16 | 4 | Doraiswamy Vinayak — Chief Scientific Officer | Sale (S): 5,000 @ $29.83 | EDGAR |
| 2026-03-12 | 4 | WHITE ROBERT S. — Director | Option exercise (M): 10,000 @ $14.99 · Option exercise (M): 10,000 (derivative) @ $14.99 | EDGAR |
| 2026-03-09 | 4 | CARREL MICHAEL H — President, CEO, & Director, Director | Gift (G): 5,000 @ $0 · Gift (G): 1,000 @ $0 | EDGAR |
| 2026-03-03 | 4 | Doraiswamy Vinayak — Chief Scientific Officer | Grant/award (A): 30,390 @ $0 · Grant/award (A): 15,198 @ $0 · Tax withholding (F): 15,585 @ $31.26 | EDGAR |
| 2026-03-03 | 4 | Dahlquist Karl S. — Chief Legal Officer | Grant/award (A): 27,991 @ $0 · Grant/award (A): 15,198 @ $0 · Tax withholding (F): 15,687 @ $31.26 | EDGAR |
| 2026-03-03 | 4 | Wirick Angela L — Chief Financial Officer | Grant/award (A): 39,987 @ $0 · Grant/award (A): 23,101 @ $0 · Tax withholding (F): 22,965 @ $31.26 | EDGAR |
| 2026-03-03 | 4 | Noznesky Justin J — Chief Mktg & Strategy Officer | Grant/award (A): 27,991 @ $0 · Grant/award (A): 15,198 @ $0 · Tax withholding (F): 15,586 @ $31.26 | EDGAR |
| 2026-03-03 | 4 | Seith Douglas J — Chief Operating Officer | Grant/award (A): 42,386 @ $0 · Grant/award (A): 25,532 @ $0 · Tax withholding (F): 22,948 @ $31.26 | EDGAR |
| 2026-03-03 | 4 | Privitera Salvatore — Chief Technical Officer | Grant/award (A): 30,390 @ $0 · Grant/award (A): 15,198 @ $0 · Tax withholding (F): 13,127 @ $31.26 | EDGAR |
| 2026-03-03 | 4 | CARREL MICHAEL H — President, CEO, & Director, Director | Grant/award (A): 68,618 @ $0 · Grant/award (A): 101,280 @ $0 · Tax withholding (F): 72,777 @ $31.26 | EDGAR |
| 2026-01-02 | 4 | Seith Douglas J — Chief Operating Officer | Grant/award (A): 257 @ $27.37 | EDGAR |
| 2025-12-12 | 4 | CARREL MICHAEL H — President, CEO, & Director, Director | Gift (G): 4,000 @ $0 | EDGAR |
| 2025-11-26 | 4 | Noznesky Justin J — Chief Mktg & Strategy Officer | Sale (S): 5,166 @ $37.29 | EDGAR |
| 2025-11-26 | 4 | WEHRWEIN SVEN — Director | Option exercise (M): 5,033 @ $19.95 · Sale (S): 5,033 @ $37.32 · Option exercise (M): 4,967 @ $19.95 · Sale (S): 4,967 @ $38 · Option exercise (M): 5,033 (derivative) @ $0 · Option exercise (M): 4,967 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | Yuen Maggie — Director | Sale (S): 3,000 @ $35.72 | EDGAR |
| 2025-11-17 | 4 | CARREL MICHAEL H — President, CEO, & Director, Director | Gift (G): 6,000 @ $0 | EDGAR |
| 2025-09-16 | 4 | Noznesky Justin J — Chief Mktg & Strategy Officer | Sale (S): 3,000 @ $36.30 | EDGAR |
| 2025-08-26 | 4 | WEHRWEIN SVEN — Director | Option exercise (M): 5,000 @ $19.95 · Sale (S): 5,000 @ $37 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-08-21 | 4 | WEHRWEIN SVEN — Director | Option exercise (M): 5,000 @ $19.95 · Sale (S): 5,000 @ $36 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | CARREL MICHAEL H — President, CEO, & Director, Director | Gift (G): 10,000 @ $0 | EDGAR |
| 2025-08-08 | 4 | GROVES REGINA E — Director | Sale (S): 2,452 @ $36.82 | EDGAR |
| 2025-08-07 | 4 | Doraiswamy Vinayak — Chief Scientific Officer | Sale (S): 2,500 @ $36.58 | EDGAR |
| 2025-07-02 | 4 | Privitera Salvatore — Chief Technical Officer | Grant/award (A): 822 @ $25.84 | EDGAR |
| 2025-07-02 | 4 | Dahlquist Karl S. — Chief Legal Officer | Grant/award (A): 822 @ $25.84 | EDGAR |
| 2025-07-02 | 4 | CARREL MICHAEL H — President, CEO, & Director, Director | Grant/award (A): 822 @ $25.84 | EDGAR |
Recent 8-K events — AtriCure, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-06 | 8-K/A | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-29 | 8-K/A | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ATRC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →